	ASO Visual Abstract: Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients With Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial. Ann Surg Oncol Mor E, Apte S, Bressel M, Broman KK, Hieken TJ, Olofsson Bagge R, Berman RS, Lee AY, Kuijpers AM, Ollila DW, van Akkooi ACJ, Zager JS, Gyorki DE. PMID: 41838356 [PubMed - as supplied by publisher]
	Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma. Discov Oncol Urbonas V, Dulskas A. PMID: 41838305 [PubMed - as supplied by publisher]
	Quercetin's Multifaceted Role in Alzheimer's Disease, Melanoma, and Tuberculosis: A Systematic Review with Preclinical Insights. Curr Pharm Des Pratap Swain M, Mohanty S, Gupta N, Mukherjee T, Kumar Singh S, Pattnaik A. PMID: 41837588 [PubMed - as supplied by publisher]
	Efficacy and safety of CTLA-4, PD-1 and LAG-3 immune checkpoint inhibitors as monotherapy and combination therapy in advanced melanoma: A systematic review and meta-analysis. EXCLI J Omar Khan O. PMID: 41834910 [PubMed]
	Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study. Int J Cancer Gutzmer R, Weichenthal M, Eigentler T, Mohr P, Sickmann T, Dücker P, Gebhardt C, Haferkamp S, Kähler KC, Meier F, Pföhler C, Sindrilaru A, Terheyden P, von Wasielewski I, Ugurel S, Ulrich J, Utikal J, Weishaupt C, Schadendorf D. PMID: 41833546 [PubMed - as supplied by publisher]
	High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy regardless of gut microbiome dysbiosis and social vulnerability. Cancer Fields BC, Traweek RS, Jiang K, Witt RG, Damania A, Chiang YJ, Ajami N, Nassif-Haddad E, Keung EZ, Chelvanambi M, Zhang X, Peterson CB, Wargo JA, Daniel CR, Roland CL, Holder AM. PMID: 41832741 [PubMed - indexed for MEDLINE]
	Precision Design in Cancer Treatment: Cucurbitacin E Modulates AMPK, PGK1, and PKM2 to Optimize Radiation Efficacy in Melanoma. Curr Pharm Des Abdelrhman IG, Hamdy AM, Abdalla Hussein M, Emara AA, Mohamed SF, Azmy Boshra S, Atef Mahmoud A. PMID: 41832669 [PubMed - as supplied by publisher]
	CD27 expression is a clinically accessible biomarker for predicting immunotherapy response in melanoma. NPJ Precis Oncol Xia P, Yang H, Yu P, Miao Y, Tang L, Wang Y, Li B, Wang Z, Jiang G, Chen K, Li S, Yang M. PMID: 41832290 [PubMed - as supplied by publisher]
	Cutaneous Melanoma: Association of Histopathological Subtypes and Breslow Thickness with Occupation and Residence in An observational study of 2,486 patients. Actas Dermosifiliogr Angel-Baldo J, Stoicev O, Barceló C, Matas-Nadal C, Soria X, Gatius S, Murata P, Nagore E, Marti RM. PMID: 41831776 [PubMed - as supplied by publisher]
	Frailty and survival outcomes in veterans with invasive cutaneous melanoma: A Veterans Affairs Cancer Registry retrospective cohort study. J Am Acad Dermatol Huhmann LB, Hwang JC, Kim DY, Nannini K, Do NV, Gaziano JM, Wheless LE, Fillmore NR, Hartman RI. PMID: 41831612 [PubMed - as supplied by publisher]
	The impact of type 2 diabetes on sex- and stage-specific melanoma recurrence and mortality: A Danish cohort study, 2004 to 2024. Br J Dermatol Lyngstrand JE, Røssell EL, Bønnelykke-Behrndtz ML, Laurberg T. PMID: 41831481 [PubMed - as supplied by publisher]
	Surgical Management of Stage IV Melanoma: Clinical, Molecular, and Therapeutic Considerations. Int J Mol Sci Uche IK, Lyons JM 3rd. PMID: 41828551 [PubMed - indexed for MEDLINE]
	Dermoscopy of Cutaneous Melanoma Metastases: A Comprehensive Literature Review. Diagnostics (Basel) D'Onghia M, Agueci S, Scotti B, Falcinelli F, Lo Conte S, Cartocci A, Cortez CD, Dika E, Tognetti L, Rubegni P, Perrot J, Cinotti E. PMID: 41828014 [PubMed]
	Impact on Quality of Life and Psychological Dimensions in Caregivers of Melanoma and Sarcoma Patients: A Scoping Review. Cancers (Basel) Lleshi K, Shams M, Bergo E, Pluti M, Mocellin S, Del Fiore P, Feltrin A. PMID: 41827744 [PubMed]
	Adverse Events and Toxicity of Systemic Treatments for Uveal Melanoma: A Systematic Review. Cancers (Basel) Lanzafame K, Blanco G, Paratore S, Maratta MG, Russo A, Asero S, Ursino MG, Marino P, Bordonaro R. PMID: 41827715 [PubMed]
	Methods to include environmental impacts in a cost-effectiveness analysis: a case study of PET/CT surveillance imaging after treatment for stage III melanoma. Value Health Williams JTW, Bell KJL, McAlister S, Morton RL. PMID: 41825799 [PubMed - as supplied by publisher]
	Authors' reply regarding "Does tattoo exposure increase the risk of cutaneous melanoma: A population based case-control study". Eur J Epidemiol Rietz Liljedahl E, Nielsen K, Engfeldt M, Saxne Jöud A, Nielsen C. PMID: 41824157 [PubMed - as supplied by publisher]
	ACR Appropriateness CriteriaÂ® Staging and Follow-Up of Melanoma. J Am Coll Radiol Expert Panel on Systemic Oncology, Mejias C, Morgan RL, Arora SS, Carter BW, Chundury A, Corey AS, Kim L, Morin CE, Swami U, Terando A, Vorenkamp AE, Wolfman DJ, Wong TZ. PMID: 41823939 [PubMed - as supplied by publisher]
	The integrated 31-gene expression profile test identifies low-risk patients with cutaneous melanoma who can forego the SLNB procedure: results from a prospective, multicenter trial. Future Oncol Beard T, Guenther JM, Leong SP, Yamamoto M, Dierks S, Sickle-Santanello B, Ward A, Cripe M, Shah P, Young S. PMID: 41823171 [PubMed - as supplied by publisher]
	Associations of Social and Demographic Factors on the Outcomes of Ocular Melanoma and Other Adult Ocular Neoplasms in the United States: A Systematic Review. Cochrane Evid Synth Methods Shaughnessy D, Joshi V, Dellavalle N, Leslie L, Edwards M, Waxweiler T, Li T, Qureshi R. PMID: 41822909 [PubMed]

Articles 1 - 20 / 45329

Page 1 of 2267



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy